Market Place
Sourcing Support
ASLAN`s TreeTopp global pivotal study of varlitinib in biliary tract cancer
13 Nov 2019 //
PHARMABIZ
Aslan`s varlitinib hopes fade after latest failure
12 Nov 2019 //
FIERCE BIOTECH
Aslan`s Presents Late-breaking Data From Ph2 Study In China Testing Varlitinib
25 Sep 2019 //
BIOSPACE
Takeda’s dengue shot; Pfizer’s China Ibrance deal; Aslan job cuts
01 Feb 2019 //
FIERCE PHARMA
Aslan turns focus to biliary tract cancer as lead drug flops in PhII study
14 Jan 2019 //
ENDPTS
ASLAN Pharmaceuticals Completes Recruitment for Phase 2 Study for Varlitinib
10 Aug 2018 //
BIOSPACE
ASLAN Pharma to present two posters on varlitinib at ASCO
17 May 2018 //
BIOSPECTRUM
Aslan to make Array`s small molecule cancer drug varlitinib new licensing deal
08 Jan 2018 //
IN PHARMATECHNOLOGIST
ASLAN posts positive top-line varlitinib phase 2 data in breast cancer
16 Feb 2017 //
FIERCE PHARMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.